Platform
Company
Coagulation studies (PT/INR, aPTT, fibrinogen, D‑dimer)
AT activity
ATIII activity
D-dimer
FII 1:10
FII 1:20
FII activity
FII Activity 1:5
FII Activity (Prelim)
FII activity
FIX activity 1:10
FIX activity (1:20)
FIX Activity (1:40)
FIX activity
FIX preliminary
FIX
F5 activity 1:10
FV activity 1:20
FV Activity (1:40)
F5 activity 1:5
FV Preliminary
FV activity
FVII 1:10
FVII 1:20
FVII activity
FVII activity 1:5
FVII Preliminary
FVII
FVIII activity 1:10
FVIII 1:20
FVIII activity (1:40)
FVIII activity (1:5)
FVIII prelim
VWF:RCo
FVIII
FX Activity 1:10
FX 1:20
FX activity 1:40
FX activity (1:5)
FX Preliminary
FX activity
FXI activity (1:10)
FXI 1:20
FXI 1:5
FXI Preliminary
FXI
FXII activity (1:10)
FXII activity (1:20)
FXII activity 1:40
Factor XII (1:5)
FXII activity (prelim)
FXII activity
FXIII prelim
FXIII
FIB-HA
FIB
Heparin-adjusted INR
LA aPTT
Protein C prelim
Protein S Free (Prelim)
PS Free
FXI activity
VWF:Ag